Manifold MarketsKYC yokDoğrulanmış sonuçlanma verisiİyi kalibreGüncel topluluk tahmini2030 69.2%5 seçenek arasında lider
Tahminciler
3
Soru türü
multiple choice
Yöntem
Play-money forecasting platform
Kaynak türü
Tahmin
7g Değişim
0.0 pts
Piyasa verileri
13 saat önce güncellendi
Guncelligini yitirmis13 Haz 26 23:07 UTC31 Ara 30 23:59 UTC
Trendler
İlgili Piyasalar
Bağlam için ilgili sorular; eşdeğer sözleşmelerin karşılaştırması değildir.
Will there be a ban on Chinese biotech trials by US-based companies by EOY2027?
Manifold MarketsWill a majority government owned company introduce a new GLP-1 drug before 2040?
Manifold MarketsEU adopts Chinese telecom gear phase-out law by which date?
PolymarketFDA decision: Ivonescimab by Summit Therapeutics (in 2026)
KalshiWill WW3 start before gta6?
Manifold MarketsWill Ice Cream turn out to actually be "healthy" based on consensus view at EOY 2026?
Manifold MarketsKurallar
Resolution criteria
- This is an independent multiple-choice market.
- Each year will resolve independently as YES or NO based on whether China registers more Phase 3 clinical trials than the United States during that calendar year.
- Primary Source of Truth: The database compiled by the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP), specifically accessed via the WHO Global Observatory on Health Research and Development dashboard for "Number of clinical trial registrations by year, location, disease and phase of development".
- Resolution Rules:
- YES: If the final count of Phase 3 clinical trial registrations for China (as the trial location) is strictly greater than the count for the United States (as the trial location) for the given calendar year.